Skip to content

AVENUE THERAPEUTICS, INC.

ATXI

CIK 0001644963

← back to feed
Revenue (TTM)
$1.4M
Q1 May 2026
Net Income (TTM)
−$2.9M
+75.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.56
+29.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-217.0%
Q1 May 2026
Net Margin
-206.2%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$2.42M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
3.29M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings